- Home
- XBIO vs EVOK Comparison
XBIO vs EVOK Comparison
Compare XBIO & EVOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XBIO
- EVOK
- Stock Information
- Founded
- XBIO N/A
- EVOK 2007
- Country
- XBIO United States
- EVOK United States
- Employees
- XBIO N/A
- EVOK N/A
- Industry
- XBIO Biotechnology: Pharmaceutical Preparations
- EVOK Biotechnology: Pharmaceutical Preparations
- Sector
- XBIO Health Care
- EVOK Health Care
- Exchange
- XBIO Nasdaq
- EVOK Nasdaq
- Market Cap
- XBIO 4.2M
- EVOK 4.2M
- IPO Year
- XBIO N/A
- EVOK 2013
- Fundamental
- Price
- XBIO $3.52
- EVOK $2.70
- Analyst Decision
- XBIO Hold
- EVOK
- Analyst Count
- XBIO 1
- EVOK 0
- Target Price
- XBIO N/A
- EVOK N/A
- AVG Volume (30 Days)
- XBIO 179.8K
- EVOK 19.3K
- Earning Date
- XBIO 08-12-2025
- EVOK 08-12-2025
- Dividend Yield
- XBIO N/A
- EVOK N/A
- EPS Growth
- XBIO N/A
- EVOK N/A
- EPS
- XBIO N/A
- EVOK N/A
- Revenue
- XBIO $2,582,728.00
- EVOK $11,594,083.00
- Revenue This Year
- XBIO $14.23
- EVOK $57.82
- Revenue Next Year
- XBIO $7.14
- EVOK $59.12
- P/E Ratio
- XBIO N/A
- EVOK N/A
- Revenue Growth
- XBIO 5.63
- EVOK 89.89
- 52 Week Low
- XBIO $2.20
- EVOK $1.94
- 52 Week High
- XBIO $5.27
- EVOK $12.32
- Technical
- Relative Strength Index (RSI)
- XBIO 60.67
- EVOK 43.42
- Support Level
- XBIO $3.52
- EVOK $2.50
- Resistance Level
- XBIO $4.09
- EVOK $2.84
- Average True Range (ATR)
- XBIO 0.54
- EVOK 0.20
- MACD
- XBIO 0.09
- EVOK -0.01
- Stochastic Oscillator
- XBIO 45.17
- EVOK 47.45
About XBIO Xenetic Biosciences Inc.
Xenetic Biosciences Inc is a biopharmaceutical company focused on advancing innovative immuno-oncology technologies addressing difficult to treat cancers. The company's DNase technology is designed to improve outcomes of existing treatments, including immunotherapies, by targeting neutrophil extracellular traps (NETs), which are involved in the progression of many human cancers. Xenetic is also focused on advancing its systemic DNase program into the clinic as an adjunctive therapy for pancreatic carcinoma and other locally metastatic solid tumors.
About EVOK Evoke Pharma Inc.
Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.